| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.4 | 0.2 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.086 | 0.2 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.2 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |